Cargando…

Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury

Endothelial progenitor cells secrete a variety of growth factors that inhibit inflammation, promote angiogenesis and exert neuroprotective effects. Therefore, in this study, we investigated whether endothelial progenitor cell-conditioned medium might have therapeutic effectiveness for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tao, Fang, Xiao, Yin, Zong-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998635/
https://www.ncbi.nlm.nih.gov/pubmed/29863020
http://dx.doi.org/10.4103/1673-5374.232484
_version_ 1783331270925746176
author Wang, Tao
Fang, Xiao
Yin, Zong-Sheng
author_facet Wang, Tao
Fang, Xiao
Yin, Zong-Sheng
author_sort Wang, Tao
collection PubMed
description Endothelial progenitor cells secrete a variety of growth factors that inhibit inflammation, promote angiogenesis and exert neuroprotective effects. Therefore, in this study, we investigated whether endothelial progenitor cell-conditioned medium might have therapeutic effectiveness for the treatment of spinal cord injury using both in vitro and in vivo experiments. After primary culture of bone marrow-derived macrophages, lipopolysaccharide stimulation was used to classically activate macrophages to their proinflammatory phenotype. These cells were then treated with endothelial progenitor cell-conditioned medium or control medium. Polymerase chain reaction was used to determine mRNA expression levels of related inflammatory factors. Afterwards, primary cultures of rat spinal cord neuronal cells were prepared and treated with H(2)O(2) and either endothelial progenitor cell-conditioned medium or control medium. Hoechst 33258 and propidium iodide staining were used to calculate the proportion of neurons undergoing apoptosis. Aortic ring assay was performed to assess the effect of endothelial progenitor cell-conditioned medium on angiogenesis. Compared with control medium, endothelial progenitor cell-conditioned medium mitigated the macrophage inflammatory response at the spinal cord injury site, suppressed apoptosis, and promoted angiogenesis. Next, we used a rat model of spinal cord injury to examine the effects of the endothelial progenitor cell-conditioned medium in vivo. The rats were randomly administered intraperitoneal injection of PBS, control medium or endothelial progenitor cell-conditioned medium, once a day, for 6 consecutive weeks. Immunohistochemistry was used to observe neuronal morphology. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay was performed to detect the proportion of apoptotic neurons in the gray matter. The Basso, Beattie and Bresnahan Locomotor Rating Scale was used to evaluate the recovery of motor function of the bilateral hind limbs after spinal cord injury. Compared with the other two groups, the number of axons was increased, cavities in the spinal cord were decreased, the proportion of apoptotic neurons in the gray matter was reduced, and the Basso, Beattie and Bresnahan score was higher in the endothelial progenitor cell-conditioned medium group. Taken together, the in vivo and in vitro results suggest that endothelial progenitor cell-conditioned medium suppresses inflammation, promotes angiogenesis, provides neuroprotection, and promotes functional recovery after spinal cord injury.
format Online
Article
Text
id pubmed-5998635
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-59986352018-06-29 Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury Wang, Tao Fang, Xiao Yin, Zong-Sheng Neural Regen Res Research Article Endothelial progenitor cells secrete a variety of growth factors that inhibit inflammation, promote angiogenesis and exert neuroprotective effects. Therefore, in this study, we investigated whether endothelial progenitor cell-conditioned medium might have therapeutic effectiveness for the treatment of spinal cord injury using both in vitro and in vivo experiments. After primary culture of bone marrow-derived macrophages, lipopolysaccharide stimulation was used to classically activate macrophages to their proinflammatory phenotype. These cells were then treated with endothelial progenitor cell-conditioned medium or control medium. Polymerase chain reaction was used to determine mRNA expression levels of related inflammatory factors. Afterwards, primary cultures of rat spinal cord neuronal cells were prepared and treated with H(2)O(2) and either endothelial progenitor cell-conditioned medium or control medium. Hoechst 33258 and propidium iodide staining were used to calculate the proportion of neurons undergoing apoptosis. Aortic ring assay was performed to assess the effect of endothelial progenitor cell-conditioned medium on angiogenesis. Compared with control medium, endothelial progenitor cell-conditioned medium mitigated the macrophage inflammatory response at the spinal cord injury site, suppressed apoptosis, and promoted angiogenesis. Next, we used a rat model of spinal cord injury to examine the effects of the endothelial progenitor cell-conditioned medium in vivo. The rats were randomly administered intraperitoneal injection of PBS, control medium or endothelial progenitor cell-conditioned medium, once a day, for 6 consecutive weeks. Immunohistochemistry was used to observe neuronal morphology. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay was performed to detect the proportion of apoptotic neurons in the gray matter. The Basso, Beattie and Bresnahan Locomotor Rating Scale was used to evaluate the recovery of motor function of the bilateral hind limbs after spinal cord injury. Compared with the other two groups, the number of axons was increased, cavities in the spinal cord were decreased, the proportion of apoptotic neurons in the gray matter was reduced, and the Basso, Beattie and Bresnahan score was higher in the endothelial progenitor cell-conditioned medium group. Taken together, the in vivo and in vitro results suggest that endothelial progenitor cell-conditioned medium suppresses inflammation, promotes angiogenesis, provides neuroprotection, and promotes functional recovery after spinal cord injury. Medknow Publications & Media Pvt Ltd 2018-05 /pmc/articles/PMC5998635/ /pubmed/29863020 http://dx.doi.org/10.4103/1673-5374.232484 Text en Copyright: © 2018 Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Research Article
Wang, Tao
Fang, Xiao
Yin, Zong-Sheng
Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury
title Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury
title_full Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury
title_fullStr Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury
title_full_unstemmed Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury
title_short Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury
title_sort endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998635/
https://www.ncbi.nlm.nih.gov/pubmed/29863020
http://dx.doi.org/10.4103/1673-5374.232484
work_keys_str_mv AT wangtao endothelialprogenitorcellconditionedmediumpromotesangiogenesisandisneuroprotectiveafterspinalcordinjury
AT fangxiao endothelialprogenitorcellconditionedmediumpromotesangiogenesisandisneuroprotectiveafterspinalcordinjury
AT yinzongsheng endothelialprogenitorcellconditionedmediumpromotesangiogenesisandisneuroprotectiveafterspinalcordinjury